85-2602-41　17-PA 50mg　CAS No:694438-95-4　254348

特徴

• Selective antagonist of neurosteroid potentiation and direct gating of GABAA receptors. Selectively reduces the effects of 5α-reduced steroids compared to 5β-reduced steroids and displays no effect on potentiation evoked by barbiturates and benzodiazepines. Attenuates 3α,5α-THP-induced loss of righting reflex and total sleep time following i.c.v administration in rats.
• Synonym:17-Phenyl-(3α,5α)-androst-16-en-3-ol
• Molecular Weight:350.54
• Molecular Formula:C25H34O
• Solubility:DMSO to 25mM, ethanol to 50mM
• TLC:Rf=0.23 (Ethyl acetate:Petroleum ether [1:7])
• Method for Determining Identity:Proton NMR and Mass Spectrometric Analysis
• Appearance:Supplied as a white solid.
• Purity:≥99% (HPLC)
• Storage and Stability:Store at 4°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

仕様

• Size：50mg
• Grade：Highly Purified
• Purity：≥99% (HPLC)
• Form：Supplied as a white solid.
• Molecular Formula：C25H34O
• Molecular Weight Non Ab：350.54
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
• CAS No ：694438-95-4

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]